Suppr超能文献

GIP受体激活白色脂肪组织中无效的钙循环,以增加能量消耗并促使小鼠体重减轻。

The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice.

作者信息

Yu Xinxin, Chen Shiuhwei, Funcke Jan-Bernd, Straub Leon G, Pirro Valentina, Emont Margo P, Droz Brian A, Collins Kyla Ai, Joung Chanmin, Pearson Mackenzie J, James Corey M, Babu Gopal J, Efthymiou Vissarion, Vernon Ashley, Patti Mary Elizabeth, An Yu A, Rosen Evan D, Coghlan Matthew P, Samms Ricardo J, Scherer Philipp E, Kusminski Christine M

机构信息

Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Eli Lilly Research Laboratories, Division of Eli Lilly and Company, Indianapolis, IN 46285, USA.

出版信息

Cell Metab. 2025 Jan 7;37(1):187-204.e7. doi: 10.1016/j.cmet.2024.11.003. Epub 2024 Dec 5.

Abstract

Obesity is a chronic disease that contributes to the development of insulin resistance, type 2 diabetes (T2D), and cardiovascular risk. Glucose-dependent insulinotropic polypeptide (GIP) receptor (GIPR) and glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) co-agonism provide an improved therapeutic profile in individuals with T2D and obesity when compared with selective GLP-1R agonism. Although the metabolic benefits of GLP-1R agonism are established, whether GIPR activation impacts weight loss through peripheral mechanisms is yet to be fully defined. Here, we generated a mouse model of GIPR induction exclusively in the adipocyte. We show that GIPR induction in the fat cell protects mice from diet-induced obesity and triggers profound weight loss (∼35%) in an obese setting. Adipose GIPR further increases lipid oxidation, thermogenesis, and energy expenditure. Mechanistically, we demonstrate that GIPR induction activates SERCA-mediated futile calcium cycling in the adipocyte. GIPR activation further triggers a metabolic memory effect, which maintains weight loss after the transgene has been switched off, highlighting a unique aspect in adipocyte biology. Collectively, we present a mechanism of peripheral GIPR action in adipose tissue, which exerts beneficial metabolic effects on body weight and energy balance.

摘要

肥胖是一种慢性疾病,会导致胰岛素抵抗、2型糖尿病(T2D)以及心血管风险的发展。与选择性胰高血糖素样肽-1受体(GLP-1R)激动剂相比,葡萄糖依赖性促胰岛素多肽(GIP)受体(GIPR)和GLP-1R共同激动剂在T2D和肥胖个体中具有更好的治疗效果。尽管GLP-1R激动剂的代谢益处已得到证实,但GIPR激活是否通过外周机制影响体重减轻尚未完全明确。在此,我们构建了仅在脂肪细胞中诱导GIPR的小鼠模型。我们发现脂肪细胞中GIPR的诱导可保护小鼠免受饮食诱导的肥胖,并在肥胖状态下引发显著的体重减轻(约35%)。脂肪组织中的GIPR进一步增加脂质氧化、产热和能量消耗。从机制上讲,我们证明GIPR的诱导激活了脂肪细胞中受磷蛋白(SERCA)介导的无效钙循环。GIPR激活还会触发一种代谢记忆效应,在转基因关闭后仍能维持体重减轻,突出了脂肪细胞生物学的一个独特方面。总体而言,我们提出了脂肪组织中GIPR外周作用的机制,其对体重和能量平衡产生有益的代谢影响。

相似文献

1
The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice.
Cell Metab. 2025 Jan 7;37(1):187-204.e7. doi: 10.1016/j.cmet.2024.11.003. Epub 2024 Dec 5.
5
The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets.
Nat Metab. 2023 Jun;5(6):945-954. doi: 10.1038/s42255-023-00811-0. Epub 2023 Jun 5.
6
Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.
Mol Metab. 2019 Feb;20:51-62. doi: 10.1016/j.molmet.2018.12.001. Epub 2018 Dec 5.
9
Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease.
Endocr Rev. 2025 Jul 15;46(4):479-500. doi: 10.1210/endrev/bnaf006.

引用本文的文献

1
Adipose Tissue, at the Core of the Action of Incretin and Glucagon-Based Anti-Obesity Drugs.
Curr Obes Rep. 2025 Sep 2;14(1):67. doi: 10.1007/s13679-025-00660-w.
2
Comparative ocular outcomes of tirzepatide versus other anti-obesity medications in people with obesity.
Commun Med (Lond). 2025 Aug 1;5(1):329. doi: 10.1038/s43856-025-01066-4.
4
Creatine kinase B mediates UCP1-independent beige fat thermogenesis via the futile creatine cycle in mice.
Mol Metab. 2025 Aug;98:102193. doi: 10.1016/j.molmet.2025.102193. Epub 2025 Jun 23.
5
Adipose tissue ageing: implications for metabolic health and lifespan.
Nat Rev Endocrinol. 2025 Jun 23. doi: 10.1038/s41574-025-01142-8.
6
A Contemporary Rationale for Agonism of the GIP Receptor in the Treatment of Obesity.
Diabetes. 2025 Aug 1;74(8):1326-1333. doi: 10.2337/dbi24-0026.
7
Therapeutic Targeting of the GIP Receptor-Revisiting the Controversies.
Diabetes. 2025 Aug 1;74(8):1320-1325. doi: 10.2337/db25-0393.
8
The evolution of the therapeutic concept 'GIP receptor antagonism'.
Front Endocrinol (Lausanne). 2025 May 21;16:1570603. doi: 10.3389/fendo.2025.1570603. eCollection 2025.
9
10
Physiology and clinical applications of GIP.
Endocr J. 2025 Jul 1;72(7):751-764. doi: 10.1507/endocrj.EJ25-0087. Epub 2025 Apr 3.

本文引用的文献

2
Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor.
Cell Metab. 2024 Jul 2;36(7):1534-1549.e7. doi: 10.1016/j.cmet.2024.05.010. Epub 2024 Jun 14.
3
Adipocytes control food intake and weight regain via Vacuolar-type H ATPase.
Nat Commun. 2022 Aug 30;13(1):5092. doi: 10.1038/s41467-022-32764-5.
4
Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue.
Mol Metab. 2022 Oct;64:101550. doi: 10.1016/j.molmet.2022.101550. Epub 2022 Jul 31.
5
Tirzepatide Once Weekly for the Treatment of Obesity.
N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4.
6
Calcium cycling as a mediator of thermogenic metabolism in adipose tissue.
Mol Pharmacol. 2022 May 3;102(1):51-9. doi: 10.1124/molpharm.121.000465.
7
GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior.
Diabetes. 2022 Jul 1;71(7):1410-1423. doi: 10.2337/db21-0848.
8
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.
Diabetes Obes Metab. 2022 Aug;24(8):1553-1564. doi: 10.1111/dom.14725. Epub 2022 May 19.
9
A single-cell atlas of human and mouse white adipose tissue.
Nature. 2022 Mar;603(7903):926-933. doi: 10.1038/s41586-022-04518-2. Epub 2022 Mar 16.
10
GIPR Is Predominantly Localized to Nonadipocyte Cell Types Within White Adipose Tissue.
Diabetes. 2022 May 1;71(5):1115-1127. doi: 10.2337/db21-1166.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验